In this section:

08 September 2026

Treatment update – September 2026

We have received stock updates from manufacturers regarding a number of psoriasis lotions, ointments and shampoos.  

This information is correct at the time of writing (September 2026). Please continue to check our unavailable treatments page for the latest updates.

Eumovate Ointment 0.05% (100g tubes) - out of stock 

There have been a number of stock concerns with Eumovate Cream and Eumovate Ointment (0.05%) in recent months. 

Manufacturers Glaxo Smith Kline (GSK) have confirmed that Eumovate Cream (30g tubes) are now back in stock, following a period of unavailability. However, issues with Eumovate Ointment (100g tubes) are ongoing, and this product is now out of stock until early November. 

If you have any further questions, please reach out to GSK via email at customercontactuk@gsk.com

Elocon Ointment 100g - out of stock 

Organon Pharma confirmed that there has been some stock issues with Elocon Ointment (100g tubes), but have confirmed that they will be back in stock from Sunday, 8 November 2026. (Original date was advised to be 31 August). Please be aware that it may take a few days for stock to reach pharmacies once reordered through Alliance Healthcare Wholesalers. 

Members have also contacted us within the last month with regards to Elocon Scalp Lotion (30ml), however, we understand this is now back in stock. 

If you have any queries regarding Elocon Ointment or Scalp Lotion, patients can contact Organon Pharma’s Customer Care direct line on +44 (0) 208 159 3500. 

Diprosalic Scalp Lotion - out of stock 

Organon Pharma, the manufacturers of Diprosalic Scalp Lotion, have confirmed that this product is currently out of stock, and is expected to return to market from Sunday, 27 September 2026. 

If you have any queries regarding Diprosalic Scalp Lotion, patients can contact Organon Pharma’s Customer Care direct line on +44 (0) 208 159 3500. 

Ceanel Shampoo – potential return to market 

We have remained in touch with Derma UK regarding the potential return to market for Ceanel Concentrate Medicated Shampoo, pending assessment and approval from the Medicines and Healthcare products Regulatory Agency (MHRA). Derma UK have recently reported to Psoriasis UK that the re-development of Ceanel is ongoing. Their full statement is available on our unavailable treatments page. 

We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you. If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them. Close